INM logo

InMed Pharmaceuticals (INM) Shareholders Equity

Annual Shareholders Equity

$9.21 M
-$2.88 M-23.85%

June 30, 2024

Summary

Performance

1-Year Change

-23.85%

3-Year Change

+24.8%

5-Year Change

-33.69%

15-Year Change

+50.29%

INM Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.02%
INM annual stockholders equity is higher than 31.02% of companies in Healthcare sector

High & Low

All-time High

$20.62 M
INM annual stockholders equity is currently -55.36% below its historical high of $20.62 million

3-Year Low

$7.38 M
INM annual stockholders equity is currently +24.80% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
INM previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
INM next annual earnings announcement has not yet been scheduled

OtherINMbalance sheetmetrics:

Annual Retained Earnings

-$109.08 M
INM annual retained earnings is -$109.08 million

Annual Working Capital

$6.72 M
INM annual working capital is $6.72 million

Annual Total Assets

$11.82 M
INM annual total assets is $11.82 million

Annual Total Liabilities

$2.62 M
INM annual total liabilities is $2.62 million

Quarterly Shareholders Equity

$8.40 M
-$810.70 K-8.81%

September 30, 2024

Summary

Performance

3-Month Change

-8.81%

1-Year Change

-24.4%

3-Year Change

-7.52%

5-Year Change

+10.6%

INM Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

29.45%
INM quarterly stockholders equity is higher than 29.45% of companies in Healthcare sector

High & Low

All-time High

$20.62 M
INM quarterly stockholders equity is currently -59.29% below its historical high of $20.62 million

3-Year Low

$8.40 M
INM quarterly stockholders equity is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
INM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
INM next earnings announcement is scheduled for Feb 13, 2025

OtherINMbalance sheetmetrics:

Quarterly Retained Earnings

-$110.75 M
INM quarterly retained earnings is -$110.75 million

Quarterly Working Capital

$5.84 M
INM quarterly working capital is $5.84 million

Quarterly Total Assets

$10.47 M
INM quarterly total assets is $10.47 million

Quarterly Total Liabilities

$2.07 M
INM quarterly total liabilities is $2.07 million

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

Annual Shareholders Equity

$9.21 M
INM annual stockholders equity is $9.21 million

Annual Total Assets

$11.82 M
INM annual total assets is $11.82 million

Annual Total Liabilities

$2.62 M
INM annual total liabilities is $2.62 million

INM Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-23.9%-24.4%
3 y3 years+24.8%-7.5%
5 y5 years-33.7%+10.6%

INM Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-23.9%+24.8%-41.4%at low
5 y5-year-33.7%+56.6%-44.9%+86.8%
alltimeall time-55.4%+907.3%-59.3%+741.4%

InMed Pharmaceuticals Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$8.40 M(-8.8%)
Jun 2024
$9.21 M(-23.9%)
$9.21 M(-17.1%)
Mar 2024
-
$11.10 M(-13.1%)
Dec 2023
-
$12.77 M(+33.3%)
Sep 2023
-
$9.58 M(-20.8%)
Jun 2023
$12.09 M(+33.2%)
$12.09 M(-2.4%)
Mar 2023
-
$12.39 M(-13.6%)
Dec 2022
-
$14.34 M(+30.2%)
Sep 2022
-
$11.01 M(+21.3%)
Jun 2022
$9.08 M(+23.1%)
$9.08 M(-16.6%)
Mar 2022
-
$10.89 M(-23.2%)
Dec 2021
-
$14.17 M(-6.9%)
Sep 2021
-
$15.22 M(+106.4%)
Jun 2021
$7.38 M(+25.5%)
$7.38 M(-29.2%)
Mar 2021
-
$10.41 M(+37.2%)
Dec 2020
-
$7.59 M(+68.9%)
Sep 2020
-
$4.49 M(-23.5%)
Jun 2020
$5.88 M(-57.7%)
$5.88 M(-13.5%)
Mar 2020
-
$6.80 M(-26.5%)
Dec 2019
-
$9.25 M(-18.3%)
Sep 2019
-
$11.32 M(-18.4%)
Jun 2019
$13.88 M(-32.7%)
$13.88 M(-14.5%)
Mar 2019
-
$16.24 M(-8.2%)
Dec 2018
-
$17.69 M(-11.2%)
Sep 2018
-
$19.91 M(-3.5%)
Jun 2018
$20.62 M(+236.7%)
$20.62 M(+81.2%)
Mar 2018
-
$11.38 M(-0.5%)
Dec 2017
-
$11.44 M(+91.9%)
Sep 2017
-
$5.96 M(-2.7%)
Jun 2017
$6.13 M(+646.5%)
$6.13 M(+98.4%)
Mar 2017
-
$3.09 M(+105.0%)
Dec 2016
-
$1.51 M(+58.7%)
Sep 2016
-
$949.60 K(+15.7%)
Jun 2016
$820.50 K(-35.7%)
$820.50 K(+63.8%)
Mar 2016
-
$500.80 K(-30.2%)
Dec 2015
-
$717.40 K(-22.1%)
Sep 2015
-
$921.50 K(-27.8%)
Jun 2015
$1.28 M(-16.1%)
$1.28 M(+42.0%)
Mar 2015
-
$898.30 K(+0.0%)
Dec 2014
-
$898.20 K(-28.8%)
Sep 2014
-
$1.26 M(-17.0%)
Jun 2014
$1.52 M(-3546.3%)
$1.52 M(-951.4%)
Mar 2014
-
-$178.50 K(+99.4%)
Dec 2013
-
-$89.50 K(+59.8%)
Sep 2013
-
-$56.00 K(+27.0%)
Jun 2013
-$44.10 K
-$44.10 K(+107.0%)
Mar 2013
-
-$21.30 K(+52.1%)
DateAnnualQuarterly
Dec 2012
-
-$14.00 K(-30.3%)
Sep 2012
-
-$20.10 K(-844.4%)
Jun 2012
$2700.00(-98.7%)
$2700.00(-97.4%)
Mar 2012
-
$104.90 K(-15.8%)
Dec 2011
-
$124.60 K(-16.1%)
Sep 2011
-
$148.50 K(-26.6%)
Jun 2011
$202.30 K(-117.7%)
$202.30 K(-3.8%)
Mar 2011
-
$210.30 K(-116.3%)
Dec 2010
-
-$1.29 M(+5.9%)
Sep 2010
-
-$1.22 M(+6.8%)
Jun 2010
-$1.14 M(+10.8%)
-$1.14 M(-9.9%)
Mar 2010
-
-$1.27 M(-3.3%)
Dec 2009
-
-$1.31 M(+9.4%)
Sep 2009
-
-$1.20 M(+16.3%)
Jun 2009
-$1.03 M(+640.3%)
-$1.03 M(-10.4%)
Mar 2009
-
-$1.15 M(+3.1%)
Dec 2008
-
-$1.11 M(+4.9%)
Sep 2008
-
-$1.06 M(+664.3%)
Jun 2008
-$139.00 K(-85.4%)
-$139.00 K(+52.4%)
Mar 2008
-
-$91.20 K(-72.4%)
Dec 2007
-
-$330.50 K(-58.3%)
Sep 2007
-
-$792.90 K(-16.6%)
Jun 2007
-$950.40 K(+95.8%)
-$950.40 K(+117.7%)
Mar 2007
-
-$436.50 K(-39.5%)
Dec 2006
-
-$721.60 K(+186.7%)
Sep 2006
-
-$251.70 K(-48.1%)
Jun 2006
-$485.40 K(-27.6%)
-$485.40 K(+23.1%)
Mar 2006
-
-$394.20 K(+39.5%)
Dec 2005
-
-$282.60 K(-59.4%)
Sep 2005
-
-$696.10 K(+3.8%)
Jun 2005
-$670.60 K(+184.6%)
-$670.60 K(-300.1%)
Mar 2005
-
$335.20 K(-271.5%)
Dec 2004
-
-$195.50 K(-37.9%)
Sep 2004
-
-$314.90 K(+33.7%)
Jul 2004
-$235.60 K(-197.4%)
-$235.60 K(-199.5%)
Apr 2004
-
$236.80 K(+228.9%)
Jan 2004
-
$72.00 K(-49.4%)
Oct 2003
-
$142.30 K(-41.2%)
Jul 2003
$241.90 K(-81.2%)
$241.90 K(-60.1%)
Apr 2003
-
$606.10 K(-21.3%)
Jan 2003
-
$770.40 K(-23.5%)
Oct 2002
-
$1.01 M(-21.8%)
Jul 2002
$1.29 M(-69.2%)
$1.29 M(-32.7%)
Apr 2002
-
$1.91 M(-25.1%)
Jan 2002
-
$2.56 M(-22.2%)
Oct 2001
-
$3.28 M
Jul 2001
$4.18 M
-

FAQ

  • What is InMed Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for InMed Pharmaceuticals?
  • What is InMed Pharmaceuticals annual shareholders equity year-on-year change?
  • What is InMed Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for InMed Pharmaceuticals?
  • What is InMed Pharmaceuticals quarterly shareholders equity year-on-year change?

What is InMed Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of INM is $9.21 M

What is the all time high annual shareholders equity for InMed Pharmaceuticals?

InMed Pharmaceuticals all-time high annual stockholders equity is $20.62 M

What is InMed Pharmaceuticals annual shareholders equity year-on-year change?

Over the past year, INM annual stockholders equity has changed by -$2.88 M (-23.85%)

What is InMed Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of INM is $8.40 M

What is the all time high quarterly shareholders equity for InMed Pharmaceuticals?

InMed Pharmaceuticals all-time high quarterly stockholders equity is $20.62 M

What is InMed Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, INM quarterly stockholders equity has changed by -$2.71 M (-24.40%)